The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS2-4

Treatment strategies for chronic lymphocytic leukemia: p53 abnormalities as a critical biomarker for therapy optimization

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Shinji Nakao (Department of Hematology and Pulmonary Medicine, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University)

Sponsor: Janssen Pharmaceutical K.K.

[MS2-4] Treatment strategies for chronic lymphocytic leukemia: p53 abnormalities as a critical biomarker for therapy optimization

Kensuke Kojima (Division of Hematology, Respiratory Medicine and Oncology, Department of Medicine, Saga University)